JP2005517677A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517677A5
JP2005517677A5 JP2003556413A JP2003556413A JP2005517677A5 JP 2005517677 A5 JP2005517677 A5 JP 2005517677A5 JP 2003556413 A JP2003556413 A JP 2003556413A JP 2003556413 A JP2003556413 A JP 2003556413A JP 2005517677 A5 JP2005517677 A5 JP 2005517677A5
Authority
JP
Japan
Prior art keywords
aryl
lower alkyl
lower alkoxy
cycloalkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003556413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517677A (ja
JP4188839B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/014771 external-priority patent/WO2003055883A1/en
Publication of JP2005517677A publication Critical patent/JP2005517677A/ja
Publication of JP2005517677A5 publication Critical patent/JP2005517677A5/ja
Application granted granted Critical
Publication of JP4188839B2 publication Critical patent/JP4188839B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003556413A 2001-12-27 2002-12-27 ホスファターゼインヒビーターとしてのピリミドトリアジン Expired - Fee Related JP4188839B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34393701P 2001-12-27 2001-12-27
US39911002P 2002-07-26 2002-07-26
PCT/EP2002/014771 WO2003055883A1 (en) 2001-12-27 2002-12-27 Pyrimidotriazines as phosphatase inhibitors

Publications (3)

Publication Number Publication Date
JP2005517677A JP2005517677A (ja) 2005-06-16
JP2005517677A5 true JP2005517677A5 (enExample) 2005-12-22
JP4188839B2 JP4188839B2 (ja) 2008-12-03

Family

ID=26993696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003556413A Expired - Fee Related JP4188839B2 (ja) 2001-12-27 2002-12-27 ホスファターゼインヒビーターとしてのピリミドトリアジン

Country Status (19)

Country Link
US (1) US6642381B2 (enExample)
EP (1) EP1467996B1 (enExample)
JP (1) JP4188839B2 (enExample)
KR (1) KR100601769B1 (enExample)
CN (1) CN100402530C (enExample)
AT (1) ATE311388T1 (enExample)
AU (1) AU2002367190B2 (enExample)
BR (1) BR0215395A (enExample)
CA (1) CA2471265C (enExample)
DE (1) DE60207759T2 (enExample)
ES (1) ES2252554T3 (enExample)
JO (1) JO2242B1 (enExample)
MX (1) MXPA04006266A (enExample)
PA (1) PA8562901A1 (enExample)
PE (1) PE20030896A1 (enExample)
PL (1) PL371180A1 (enExample)
TW (1) TW200306313A (enExample)
UY (1) UY27606A1 (enExample)
WO (1) WO2003055883A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037328A1 (en) * 2001-10-30 2003-05-08 Applied Research Systems Ars Holding N.V. Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
ATE427951T1 (de) * 2002-11-18 2009-04-15 Hoffmann La Roche Diazinopyrimidine und ihre verwendung als proteinkinaseinhibitoren
WO2004071448A2 (en) * 2003-02-12 2004-08-26 Transtech Pharma Inc. Substituted azole derivatives as inhibitors of protein tyrosine phosphatases
CN1747936A (zh) * 2003-02-12 2006-03-15 特兰斯泰克制药公司 作为治疗试剂的取代吡咯衍生物
NZ548208A (en) * 2004-02-12 2010-09-30 Transtech Pharma Inc Substituted azole derivatives, compositions, and methods of use
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
BRPI0707338A2 (pt) * 2006-01-30 2011-05-03 Transtech Pharma Inc derivados de imidazol, composições, e métodos substituìdos de uso como inibidores de ptpase
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010083645A1 (en) * 2009-01-21 2010-07-29 Shanghai Targetdrug Co., Ltd PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014057522A1 (en) 2012-10-12 2014-04-17 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014142364A2 (en) 2013-03-15 2014-09-18 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194410B1 (en) * 1998-03-11 2001-02-27 Hoffman-La Roche Inc. Pyrazolopyrimidine and pyrazolines and process for preparation thereof
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
GB0022079D0 (en) 2000-09-08 2000-10-25 Inst Of Molecul & Cell Biology Novel protein tyrosine phosphatase inhibitor

Similar Documents

Publication Publication Date Title
JP2005517677A5 (enExample)
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2004516314A5 (enExample)
JP2005535586A5 (enExample)
JP2005539088A5 (enExample)
CA2471265A1 (en) Pyrimidotriazines as phosphatase inhibitors
RU2006133898A (ru) Производные бензимидазола и его применение
JP2006524222A5 (enExample)
JP2008519840A5 (enExample)
JP2007505877A5 (enExample)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
JP2005533835A5 (enExample)
JP2005508967A5 (enExample)
JPWO2019195124A5 (enExample)
JP2001526218A5 (enExample)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2005526024A5 (enExample)
RU2008119692A (ru) Новые 1-азабициклоалкилпроизводные для лечения психических растройств
RU2005121908A (ru) Производные зн-хиназолин-4-она
RU2004111601A (ru) Пиперидиновые производные и их применение в качестве модуляторов активности р ецепторов хемокина (в частности ccr5)
JP2004525178A5 (enExample)
JP2005517008A5 (enExample)
JP2006510606A5 (enExample)
JP2005519885A5 (enExample)
JP2005532397A5 (enExample)